Skip to content
Subscriber Only
Business
Prognosis

BioNTech to Boost Capacity, Sees Vaccine Beating New Strain

  • Companies have projected 1.3 billion doses by end of next year
  • BioNTech shot will likely work against U.K. variant, CEO says
Video player cover image
WATCH: BioNTech says the ability to make more than 1.3 billion Covid-19 doses with partner Pfizer depends on many factors.Source: Bloomberg
Updated on

Pfizer Inc. partner BioNTech SE is pursuing all its options to make more Covid-19 vaccine doses than the 1.3 billion the companies have promised to produce next year, according to the German firm’s chief executive officer.

The companies will probably know by January or February whether and how many additional doses can be produced, Ugur Sahin said late Monday in an interview. “I am confident that we will be able to increase our network capacity, but we don’t have numbers yet.”